These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
656 related items for PubMed ID: 28551329
1. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase. Montenegro-Garreaud X, Miranda RN, Reynolds A, Tang G, Wang SA, Yabe M, Wang W, Fang L, Bueso-Ramos CE, Lin P, Medeiros LJ, Lu X. Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329 [Abstract] [Full Text] [Related]
2. B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene. Baldazzi C, Iacobucci I, Luatti S, Ottaviani E, Marzocchi G, Paolini S, Stacchini M, Papayannidis C, Gamberini C, Martinelli G, Baccarani M, Testoni N. Leuk Res; 2010 Oct; 34(10):e282-5. PubMed ID: 20594995 [No Abstract] [Full Text] [Related]
3. A rare case of atypical chronic myeloid leukemia associated with t(8;22)(p11.2;q11.2)/ BCR-FGFR1 rearrangement: A case report and literature review. Washburn E, Bayerl MG, Ketterling RP, Malysz J. Cancer Genet; 2021 Nov; 258-259():69-73. PubMed ID: 34551378 [Abstract] [Full Text] [Related]
7. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL. Fioretos T, Panagopoulos I, Lassen C, Swedin A, Billström R, Isaksson M, Strömbeck B, Olofsson T, Mitelman F, Johansson B. Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971 [Abstract] [Full Text] [Related]
10. Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature. Kumar KR, Chen W, Koduru PR, Luu HS. Am J Clin Pathol; 2015 May; 143(5):738-48. PubMed ID: 25873510 [Abstract] [Full Text] [Related]
11. Cytogenetic Evolution Associated With Disease Progression in Hematopoietic Neoplasms With t(8;22)(p11;q11)/BCR-FGFR1 Rearrangement. Wang W, Tang G, Kadia T, Lu X, Li Y, Huang L, Montenegro-Garreaud X, Miranda RN, Wang SA. J Natl Compr Canc Netw; 2016 Jun; 14(6):708-11. PubMed ID: 27283163 [Abstract] [Full Text] [Related]
12. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality. Park TS, Song J, Kim JS, Yang WI, Song S, Kim SJ, Suh B, Choi JR. Cancer Genet Cytogenet; 2008 Mar; 181(2):93-9. PubMed ID: 18295660 [Abstract] [Full Text] [Related]
13. FGFR1 translocation with concurrent myeloproliferative neoplasm, systemic mastocytosis, and lymphoblastic lymphoma: a case report. Chang K, Liu JH, Yu SC, Lin CW. Hum Pathol; 2018 Apr; 74():114-121. PubMed ID: 29107667 [Abstract] [Full Text] [Related]
14. A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation. Morishige S, Oku E, Takata Y, Kimura Y, Arakawa F, Seki R, Imamura R, Osaki K, Hashiguchi M, Yakushiji K, Mizuno S, Yoshimoto K, Nagafuji K, Ohshima K, Okamura T. Acta Haematol; 2013 Apr; 129(2):83-9. PubMed ID: 23171834 [Abstract] [Full Text] [Related]
17. Molecular identification of a TPR-FGFR1 fusion transcript in an adult with myeloproliferative neoplasm, T-lymphoblastic lymphoma, and a t(1;8)(q25;p11.2). Kim SY, Kim JE, Park S, Kim HK. Cancer Genet; 2014 Jun; 207(6):258-62. PubMed ID: 25037443 [Abstract] [Full Text] [Related]
19. [Clinical pathological features of the 8p11 myeloproliferative syndrome]. Yan Z, Yang B, Wang QS, Wang LL, Han XP, Ren F, Yu L. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1321-6. PubMed ID: 21129285 [Abstract] [Full Text] [Related]
20. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib. Landberg N, Dreimane A, Rissler M, Billström R, Ågerstam H. Eur J Haematol; 2017 Nov; 99(5):442-448. PubMed ID: 28881484 [Abstract] [Full Text] [Related] Page: [Next] [New Search]